Objective: We conducted a meta-analysis of randomized clinical trials evaluating the clinical effects of ferric carboxymaltose therapy compared to other intravenous iron in improving hemoglobin and ...

The first gene therapies approved to treat sickle cell disease in December 2023 are struggling on the market. But there are glimpses of forward momentum as Vertex and Genetix Bio provide updates.

In a phase 3 trial, oral ferric citrate effectively raised hemoglobin and improved iron parameters in Taiwanese patients with iron deficiency anemia over 16 weeks. Ferric citrate significantly ...

Jillian Kubala, MS, is a registered dietitian based in Westhampton, NY. Jillian uses a unique and personalized approach to help her clients achieve optimal wellness through nutrition and lifestyle ...

Please provide your email address to receive an email when new articles are posted on . IV iron is the most cost-effective option for women with iron deficiency anemia and heavy menstrual bleeding.

IV iron dextran is most cost-effective, yielding 19.26 QALYs compared with 19.10 QALYs for oral ferrous sulfate. (HealthDay News) — Intravenous (IV) iron dextran is the most cost-effective strategy ...

IV iron dextran was the most cost-effective treatment, yielding 19.26 quality-adjusted life years at a cost of $157,500 vs 19.10 costing $152,900 for oral ferrous sulfate. HealthDay News — Intravenous ...

Within a year of initiation, a multidisciplinary project to improve screening and treatment for iron deficiency in pregnancy resulted in a sixfold rise in screening rates for iron deficiency in ...

(ORLANDO, Dec. 6, 2025) Within a year of initiation, a multidisciplinary project to improve screening and treatment for iron deficiency in pregnancy resulted in a sixfold rise in screening rates for ...

Intravenous iron treatments improve survival and hemoglobin levels in anemic patients with acute bacterial infections, except in meningitis cases. The study challenges the belief that iron infusions ...